DMAC logo

DiaMedica Therapeutics Inc. (DMAC)

Profile

Full Name

DiaMedica Therapeutics Inc.

Ticker

NASDAQ: DMAC

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

August 3, 2012

Indexes

Not included

Website

http://www.diamedica.com

Employees

27

Key Details

Price

$3.67(-4.68%)

Market cap

$157.38M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$0.60(0.00% YoY)

PE ratio

-

Next earnings date

Aug 7, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $3.67
    DMAC price is $3.67

    30-Day Relative Volume

    0.77
    DMAC 30-day relative volume is 0.77

    Price Performance

    Price Most recent change

    -4.68%
    DMAC price was down -4.68% on Jul 10, 2025

    Price YTD change

    -32.41%
    DMAC price is down -32.41% since January 1st

    Price 1-year change

    +22.33%
    DMAC price is up +22.33% year-on-year

    Price 3-year change

    +171.85%
    DMAC price is up +171.85% over the past 3 years

    Price Range

    Price All-time high

    $44.94
    DMAC price is currently -91.83% below its historical high of $44.94

    Price 3-year low

    $1.12
    DMAC price is currently +227.68% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $157.38M
    DMAC market capitalization is $157.38 million

    Market cap 3-year change

    +340.87%
    DMAC market capitalization is up +340.87% over the past 3 years

    Market cap All-time high

    $288.60M
    DMAC market capitalization is currently -45.47% below its historical high of $288.60 million

    Market cap sector rank

    49.34%
    DMAC market capitalization is higher than 49.34% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.33%
    DMAC shares outstanding is up +0.33% year-on-year

    Shares Outstanding 3-Year Change

    +62.17%
    DMAC shares outstanding is up +62.17% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.98
    DMAC beta is 0.98

    200-day SMA

    $4.71
    DMAC price is currently -22.02% below its 200-day simple moving average

    50-day SMA

    $3.94
    DMAC price is currently -6.74% below its 50-day simple moving average

    RSI

    45.67
    DMAC 14-day relative strength index is 45.67

    Volume

    0.77
    DMAC 30-day relative volume is 0.77

    ATR

    $0.27
    DMAC average true range is $0.27

    10-day Historical Volatility

    70.10%
    DMAC 10-day historical volatility is 70.10%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    -
    DMAC annual revenue value is unknown

    Revenue Analysts estimate

    -
    DMAC annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    -
    DMAC annual revenue 1-year change is unknown

    Revenue Sector rank

    -
    DMAC annual revenue is unknown

    EPS

    EPS

    -$0.60
    DMAC annual earnings per share is -$0.60

    EPS Analysts estimate

    -$0.78
    DMAC annual earnings per share is currently -22.75% lower than the consensus analysts' forecast

    EPS 1-year change

    0%
    DMAC {parameterFullLabel} has remained unchanged year-on-year

    EPS Sector rank

    65.2%
    DMAC annual earnings per share is higher than 65.2% of companies in Healthcare sector

    Profit

    Gross profit

    -
    DMAC annual gross profit value is unknown

    Gross margin

    -
    DMAC annual gross profit margin value is unknown

    Operating profit

    -$26.68M
    DMAC annual operating income is -$26.68 million

    Operating margin

    -
    DMAC annual operating profit margin value is unknown

    Net income

    -$24.44M
    DMAC annual net profit is -$24.44 million

    Net margin

    -
    DMAC annual net profit margin value is unknown

    Expenses

    Total expenses

    $26.68M
    DMAC annual total expenses is $26.68 million

    Operating expenses

    $26.68M
    DMAC annual total operating expenses is $26.68 million

    Cost of goods sold

    -
    DMAC annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $7.62M
    DMAC annual SGA is $7.62 million

    Depreciation and amortization

    $39.00K
    DMAC annual depreciation & amortization is $39.00 thousand

    Interest expense

    -
    DMAC annual interest expense value is unknown

    Income tax

    $30.00K
    DMAC annual income tax is $30.00 thousand

    EBIT & EBITDA

    EBIT

    -$26.68M
    DMAC annual earnings before interest & taxes is -$26.68 million

    EBITDA

    -$26.64M
    DMAC annual EBITDA is -$26.64 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $46.34M
    DMAC annual total assets is $46.34 million

    Non current assets

    $1.74M
    DMAC annual long term assets is $1.74 million

    Current assets

    $44.61M
    DMAC annual total current assets is $44.61 million

    Cash and cash equivalents

    $3.02M
    DMAC annual cash & cash equivalents is $3.02 million

    Accounts receivable

    $1000.00
    DMAC annual accounts receivable is $1000.00

    Inventory

    -
    DMAC annual inventory value is unknown

    Liabilities

    Total liabilities

    $5.63M
    DMAC annual total liabilities is $5.63 million

    Long term liabilities

    $237.00K
    DMAC annual total long term liabilities is $237.00 thousand

    Current liabilities

    $5.39M
    DMAC annual total current liabilities is $5.39 million

    Accounts payable

    $940.00K
    DMAC annual accounts payable is $940.00 thousand

    Debt

    Total debt

    $340.00K
    DMAC annual total debt is $340.00 thousand

    Total debt 1-year change

    -15%
    DMAC annual total debt is down -15% year-on-year

    Long term debt

    $237.00K
    DMAC annual long term debt is $237.00 thousand

    Short term debt

    $103.00K
    DMAC annual short term debt is $103.00 thousand

    Equity & Capital

    Shareholders equity

    $40.72M
    DMAC annual stockholders equity is $40.72 million

    Book value

    $40.72M
    DMAC annual book value is $40.72 million

    Retained earnings

    -$140.00M
    DMAC annual retained earnings is -$140.00 million

    Working capital

    $39.22M
    DMAC annual working capital is $39.22 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$22.08M
    DMAC annual cash flow from operations is -$22.08 million

    Cash from operations 1-year change

    -17.88%
    DMAC annual cash flow from operations is down -17.88% year-on-year

    Cash from investing

    $8.56M
    DMAC annual cash flow from investing activities is $8.56 million

    Cash from investing 1-year change

    +146.8%
    DMAC annual cash flow from investing activities is up +146.8% year-on-year

    Cash from financing

    $11.99M
    DMAC annual cash flow from financing activities is $11.99 million

    Cash from financing 1-year change

    -67.44%
    DMAC annual cash flow from financing activities is down -67.44% year-on-year

    CAPEX

    CAPEX

    -
    DMAC annual capital expenditures value is unknown

    CAPEX 1-year change

    -
    DMAC annual capital expenditures 1-year change is unknown

    Free Cash Flow

    Free cash flow

    -$22.10M
    DMAC annual free cash flow is -$22.10 million

    Free cash flow 1-year change

    -17.86%
    DMAC annual free cash flow is down -17.86% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    DMAC annual gross profit margin value is unknown

    Operating margin

    -
    DMAC annual operating profit margin value is unknown

    Net margin

    -
    DMAC annual net profit margin value is unknown

    ROA & ROE

    ROA

    -52.74%
    DMAC annual return on assets is -52.74%

    ROE

    -60.03%
    DMAC annual return on equity is -60.03%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    DMAC price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    DMAC price to earnings ratio is unknown

    PB Ratio

    PB ratio

    4.64
    DMAC price to book ratio is 4.64

    PB ratio Sector rank

    78.16%
    DMAC price to book ratio is higher than 78.16% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    DMAC price to sales ratio value is unknown

    PS ratio Sector rank

    -
    DMAC price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $155.11M
    DMAC enterprise value is $155.11 million

    Enterprise value Sector rank

    50.25%
    DMAC enterprise value is higher than 50.25% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -5.34
    DMAC EV/EBITDA is -5.34

    EV/EBITDA Sector rank

    22.78%
    DMAC EV/EBITDA is higher than 22.78% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    8.28
    DMAC annual current ratio is 8.28

    Quick ratio

    -
    DMAC annual quick ratio value is unknown

    Leverage

    Debt to equity

    0.01
    DMAC annual debt to equity ratio is 0.01

    Interest coverage ratio

    -
    DMAC annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    DMAC piotroski f-score value is unknown

    Altman Z-Score

    -
    DMAC altman z-score value is unknown

    Analyst ratings

    Recent major analysts updates

    May 29, 25 HC Wainwright & Co.
    Buy
    Mar 19, 25 HC Wainwright & Co.
    Buy
    Nov 15, 24 HC Wainwright & Co.
    Buy
    Oct 10, 24 HC Wainwright & Co.
    Buy
    Oct 7, 24 HC Wainwright & Co.
    Buy
    Aug 16, 24 Oppenheimer
    Outperform
    Mar 21, 24 Oppenheimer
    Outperform
    Mar 21, 24 Craig-Hallum
    Buy
    Jun 22, 23 Oppenheimer
    Outperform
    Jul 7, 22 Oppenheimer
    Perform

    Institutional Ownership

    Screeners with DMAC included

    Growing Shares Outstanding
    US stocks
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    Best performing stocks last 3 years
    NASDAQ Listed Companies
    • What is the ticker symbol for DiaMedica Therapeutics Inc.?
    • Does DiaMedica Therapeutics Inc. pay dividends?
    • What sector is DiaMedica Therapeutics Inc. in?
    • What industry is DiaMedica Therapeutics Inc. in?
    • What country is DiaMedica Therapeutics Inc. based in?
    • When did DiaMedica Therapeutics Inc. go public?
    • Is DiaMedica Therapeutics Inc. in the S&P 500?
    • Is DiaMedica Therapeutics Inc. in the NASDAQ 100?
    • Is DiaMedica Therapeutics Inc. in the Dow Jones?
    • When was DiaMedica Therapeutics Inc.'s last earnings report?
    • When does DiaMedica Therapeutics Inc. report earnings?

    What is the ticker symbol for DiaMedica Therapeutics Inc.?

    The ticker symbol for DiaMedica Therapeutics Inc. is NASDAQ:DMAC

    Does DiaMedica Therapeutics Inc. pay dividends?

    No, DiaMedica Therapeutics Inc. does not pay dividends

    What sector is DiaMedica Therapeutics Inc. in?

    DiaMedica Therapeutics Inc. is in the Healthcare sector

    What industry is DiaMedica Therapeutics Inc. in?

    DiaMedica Therapeutics Inc. is in the Biotechnology industry

    What country is DiaMedica Therapeutics Inc. based in?

    DiaMedica Therapeutics Inc. is headquartered in United States

    When did DiaMedica Therapeutics Inc. go public?

    DiaMedica Therapeutics Inc.'s initial public offering (IPO) was on August 3, 2012

    Is DiaMedica Therapeutics Inc. in the S&P 500?

    No, DiaMedica Therapeutics Inc. is not included in the S&P 500 index

    Is DiaMedica Therapeutics Inc. in the NASDAQ 100?

    No, DiaMedica Therapeutics Inc. is not included in the NASDAQ 100 index

    Is DiaMedica Therapeutics Inc. in the Dow Jones?

    No, DiaMedica Therapeutics Inc. is not included in the Dow Jones index

    When was DiaMedica Therapeutics Inc.'s last earnings report?

    DiaMedica Therapeutics Inc.'s most recent earnings report was on May 13, 2025

    When does DiaMedica Therapeutics Inc. report earnings?

    The next expected earnings date for DiaMedica Therapeutics Inc. is August 7, 2025
    On this page